To The Moon

$Procter & Gamble(PG)$ upcoming fiscal Q1 2026 earnings is scheduled for Friday, October 24, 2025, before the market opens.

The stage is set for a tense quarter. Analyst expectations are modest, but the company's full-year guidance, issued in July 2025, was notably cautious, citing severe external pressures.

Earnings Per Share (EPS) : Q1 2026 analyst consensus for earnings per share is $1.90 - $1.91, prior year (Q1 2025) is $1.93, PG full-year (FY26) company guidance is estimated to be 0% to +4% (Core EPS).

Revenue : Q1 2026 analyst consensus for revenue is $22.15B - $22.23B, prior year (Q1 2025) is $21.9B, PG full-year (FY26) company guidance is estimated to be +1% to +5% (All-in Sales)

Organic Sales Growth : Q1 2026 analyst consensus for organic sales growth is Est. ~3.2% (Zacks), prior year (Q1 2025) is +2.0%, PG full-year (FY26) company guidance is estimated to be 0% to +4%.

The key takeaway is that analysts expect a slight year-over-year decline in EPS despite a slight increase in revenue. This points directly to the primary concern for this quarter: margin pressure.

Summary of Q4 2025 Earnings

Procter & Gamble closed its 2025 fiscal year with a solid fourth quarter, beating analyst expectations on both the top and bottom lines. However, the underlying details revealed a mixed picture of slowing growth and margin pressure.

EPS (Earnings Per Share): PG reported Core EPS of $1.48, a 6% increase year-over-year and ahead of the $1.42-$1.43 analyst consensus.

Revenue: The company posted $20.9 billion in sales, a 2% increase that narrowly beat the $20.8 billion consensus.

Organic Sales: Organic growth was +2%, meeting expectations.

Key Performance Drivers:

Shift Away from Volume: After showing signs of volume recovery in the previous quarter, Q4's growth was entirely driven by +1% from pricing and +1% from favorable product mix (consumers buying more premium items). Volume was flat (neutral) year-over-year.

Margin Contraction: Despite the beat, margins were a point of weakness. The core gross margin declined by 70 basis points. This was a clear sign that benefits from pricing and productivity savings were not enough to offset rising commodity costs, unfavorable mix, and new tariff impacts.

Bright Spot in China: A notable positive was the stabilization in Greater China. After declining 5% for the full fiscal year, the region posted +2% organic sales growth in Q4, signaling a potential bottoming for the struggling SK-II brand and the broader China beauty business.

The Lesson Learnt from Fiscal 2026 Guidance

The primary lesson from PG's Q4 2025 report was not about the quarter itself, but about the severe and quantifiable external headwinds detailed in its fiscal 2026 guidance.

The guidance issued was extremely cautious and reset market expectations for the year ahead:

• Organic Sales Guidance: 0% to +4% growth.

• Core EPS Guidance: 0% to +4% growth (a range of $6.83 to $7.09).

The key lesson for investors is that even a defensive giant like P&G is not immune to major macroeconomic and geopolitical pressures. The company's muted earnings forecast was a direct result of management quantifying a massive wall of costs it must absorb.

The "Lesson" Is in These Numbers:

Management was transparent that its flat-to-low-single-digit earnings guidance was after absorbing three major headwinds:

1. The Tariff Hit: A ~$1 billion (pre-tax) headwind from new and existing tariffs. This single item is expected to trim approximately six percentage points from core EPS growth.

2. Commodity Costs: A ~$200 million (after-tax) headwind from unfavorable commodity prices.

3. Interest & Tax: A ~$250 million (after-tax) headwind from higher net interest expense and a higher effective tax rate.

In essence, P&G's guidance demonstrated that its underlying business is performing well enough to generate high-single-digit earnings growth, but this is being almost entirely wiped out by external costs, particularly tariffs. The lesson is that for fiscal 2026, P&G's performance will be less about innovation and more about its ability to navigate and offset these severe, specified margin pressures.

Key Metrics Investors MUST Watch

The headline EPS and revenue numbers will be secondary. The market's reaction will be driven by these four underlying metrics.

Organic Sales: The Volume vs. Pricing Breakdown

Why it matters: This is the most critical metric. For the past two years, PG's growth was driven by raising prices (pricing) to offset inflation, while sales volume (the number of products sold) was often flat or negative. In the last reported quarter (Q4 2025), this trend finally reversed: organic sales were driven by +2% volume while pricing was flat.

What to watch: Investors will demand to see continued volume growth. If the ~3.2% organic sales growth comes from volume, it is a bullish sign of healthy demand. If it comes from more price hikes, the stock will likely sell off, as it signals weak demand.

Margin Performance (Gross & Operating)

Why it matters: PG management has explicitly warned of massive cost headwinds for fiscal 2026, including:

• ~$1 billion (pre-tax) from tariffs.

• ~$200 million (after-tax) from higher commodity costs.

• ~$250 million (after-tax) from higher interest expenses and tax rates.

What to watch: Analysts (per Zacks) are forecasting a 50-basis-point decline in core gross margin and an 80-basis-point decline in core operating margin for Q1. Any deviation from this will be significant. If PG shows it can offset these costs through productivity savings and maintain its margins better than feared, the stock will react positively. If margins crumble as expected, it will confirm the bearish case.

Performance in Greater China & SK-II

Why it matters: The premium SK-II skincare brand and the broader China market have been a major drag on PG's Beauty segment. In the year-ago quarter (Q1 2025), sales in Greater China plummeted 15%, and the SK-II brand collapsed by 35%.

What to watch: This quarter is lapping a disastrously weak comparison. This sets up an "easy beat" for the segment. Listen for any sign of stabilization or a return to growth in China. A positive surprise here could provide a much-needed offset to weakness elsewhere.

Forward-Looking Guidance (The Most Important Driver)

Why it matters: Given the low-growth, high-cost full-year guidance, the market is desperate for any update.

What to watch: The stock's post-earnings move will likely be decided by this. Does management reiterate its cautious 0-4% organic growth and 0-4% core EPS growth? Or, after seeing Q1, do they raise the low end of that range? Any negative revision or even a simple, glum reiteration of the $1B tariff impact could send the stock lower, regardless of the Q1 numbers.

Procter & Gamble (PG) Price Target

Based on 24 analysts from Tiger Brokers offering 12 month price targets for Procter & Gamble in the last 3 months. The average price target is $168.43 with a high forecast of $186.00 and a low forecast of $144.21. The average price target represents a 10.66% change from the last price of $152.20.

Short-Term Trading Opportunities & Historical Analysis

Based on historical data, trading PG for a short-term post-earnings pop is a high-risk, low-reward proposition.

The stock is famously stable and non-volatile (low beta of ~0.25). The options market is only implying a ~2.8% move in either direction, which is very small for an earnings event.

More importantly, an EPS beat does not mean the stock will go up. PG consistently beats EPS estimates (10 of the last 12 quarters), but the stock's reaction is a coin flip. This "beat and drop" phenomenon occurs when the market looks past the headline numbers and focuses on weak guidance or poor-quality metrics (e.g., low volume, falling margins).

Here is PG's 1-day stock reaction to its last four earnings reports:

• Q4 2025 (July '25): EPS Beat by $0.06. Stock Move: -0.32%

• Q3 2025 (April '25): EPS Met estimates. Stock Move: -3.74%

• Q2 2025 (Jan '25): EPS Beat by $0.02. Stock Move: +1.87%

• Q1 2025 (Oct '24): EPS Beat by $0.03. Stock Move: -0.58%

Trading Scenarios:

Bearish Case (High Probability): PG beats EPS by a penny or two but shows weak volume growth, confirms the margin decline, and reiterates its bleak full-year guidance. The stock likely drifts down 2-4%, similar to the Q3 2025 reaction. The Zacks #4 (Sell) rating and negative "Earnings ESP" support this bearish-leaning setup.

Bullish Case (Low Probability): This would require a "perfect" print:

1. A clear EPS and Revenue beat.

2. Organic sales driven by strong volume (+2% or more).

3. Margins are better than feared (e.g., flat or only slightly down).

4. Management raises the low end of its full-year EPS or organic sales guidance. In this unlikely scenario, the stock could gap up 3-5%, similar to the Q2 2024 reaction (+4.14%).

Given the severe headwinds and cautious analyst sentiment, the risk appears skewed to the downside. The most likely scenario is a modest EPS beat overshadowed by a reiteration of the punishing full-year cost and growth outlook, leading to a flat or negative stock reaction.

Technical Analysis - Exponential Moving Average (EMA)

PG have been trading in a negative RSI momentum and we can see an effort to make an upside by the bulls, but it had not been very successful, so we could be seeing another downside movement, if PG could not keep up to the margin pressure.

With the severe headwinds and cautious analyst sentiment, we might see PG gave a weak guidance, and this could lead to further share price moving downside, unless we have a significant EPS beat rather than a modest one.

Summary

 Here is a summary analysis of Procter & Gamble's (PG) upcoming fiscal Q1 2026 earnings, scheduled for October 24, 2025.

Procter & Gamble is expected to report modest results that highlight a core conflict: rising sales but shrinking profits. Analyst consensus places EPS around $1.90, slightly below the $1.93 reported in the prior-year quarter, even as revenue is expected to grow roughly 2% to $22.2 billion.

The market's focus will be entirely on margin pressure. PG's Q4 2025 report and subsequent fiscal 2026 guidance warned of severe headwinds, including a $1 billion (pre-tax) impact from tariffs and over $450 million (after-tax) from commodity and interest costs.

Investors should watch four key metrics:

1. Volume vs. Pricing: The most critical metric. Is organic sales growth (forecast around 3.2%) being driven by healthy volume (more products sold) or just more price hikes? Weak volume will be punished.

2. Margin Performance: Can productivity savings offset the massive cost headwinds? Analysts expect core gross and operating margins to decline. Beating these low expectations would be a significant win.

3. China & SK-II Performance: The Beauty segment is lapping a disastrous quarter in China last year (where sales fell 15%). This provides a low bar for a positive surprise, and any sign of stabilization would be a major catalyst.

4. Forward Guidance: The stock’s ultimate move will depend on whether management reiterates its bleak full-year 2026 guidance (0-4% core EPS growth) or signals that the worst is over.

Given the stock's low volatility and history of falling on "beats" with weak guidance, the setup appears to favor caution.

 Appreciate if you could share your thoughts in the comment section whether you think PG could provide a significant EPS modest though weak guidance.

@TigerStars @Daily_Discussion @Tiger_Earnings @TigerWire @MillionaireTiger appreciate if you could feature this article so that fellow tiger would benefit from my investing and trading thoughts.

Disclaimer: The analysis and result presented does not recommend or suggest any investing in the said stock. This is purely for Analysis.